MBChB, MMedSc, MPsych, MRCP(UK), MRCPsych, FRANZCP, FRCP(C)
Dr. Hassan is a Clinical Associate Professor of Neuropsychiatry at the University of British Columbia (UBC) and a Neuropsychiatrist within the BC Neuropsychiatry Program at UBC Hospital and the Epilepsy Program at Vancouver General Hospital. He completed his medical training at the University of Alexandria followed by a Master’s degree in Neuropathology at the University of Adelaide. Dr. Hassan then undertook postgraduate clinical training in general medicine in Perth and Melbourne culminating in Membership of the Royal College of Physicians of the UK (Internal Medicine). He undertook specialist training in General Psychiatry at the Austin Hospital in Melbourne followed by a Neuropsychiatry of Epilepsy Fellowship at the Royal Melbourne Hospital and a subsequent Neuropsychiatry Fellowship at the UBC in Vancouver. Dr. Hassan is board-certified in neuropsychiatry by the United Council for Neurologic Subspecialties.
Dr. Hassan’s clinical and research work focuses on the interaction between seizures and mental health. He launched a neuropsychiatry of epilepsy clinic at Vancouver General Hospital (www.VINEclinic.ca) and also developed a province-wide program providing shared care for non-epileptic seizures (www.ShareNES.ca). In addition, Dr. Hassan works as an inpatient neuropsychiatrist within the BC Neuropsychiatry Program (www.bcnp.ca), the province-wide tertiary referral centre for neuropsychiatry. He has been a speaker at national and international conferences in several countries including Canada, the UK, Australia and South Africa and is active in several global health initiatives involving the neuropsychiatry of epilepsy.
In addition to projects of more focused scope, larger scale research platforms for which Dr. Hassan is Principal Investigator include:
- VENbase (Vancouver Epilepsy and Neuropsyciatry Database): a prospective research platform examining various aspects of the neuropsychiatry of epilepsy and non-epileptic seizures.
- NECSA (Neuropsychiatric Effects of CNS Structural Abnormalities) study: an analysis of deeply phenotyped presentations with neuropsychiatric symptoms and central nervous system lesions, using the previously published NECSA framework.